126 related articles for article (PubMed ID: 12373738)
1. Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges.
Seeman P; Tallerico T; Ko F; Tenn C; Kapur S
Synapse; 2002 Dec; 46(4):235-9. PubMed ID: 12373738
[TBL] [Abstract][Full Text] [Related]
2. Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO.
Seeman P; McCormick PN; Kapur S
Synapse; 2007 May; 61(5):263-7. PubMed ID: 17318886
[TBL] [Abstract][Full Text] [Related]
3. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals.
Seeman P
Synapse; 2009 Mar; 63(3):186-92. PubMed ID: 19086090
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
Kiss B; Horti F; Bobok A
Synapse; 2011 Jun; 65(6):467-78. PubMed ID: 20936685
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
McCormick PN; Kapur S; Seeman P; Wilson AA
Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
[TBL] [Abstract][Full Text] [Related]
7. Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans.
Seeman P
Synapse; 2012 Jan; 66(1):88-93. PubMed ID: 21954082
[TBL] [Abstract][Full Text] [Related]
8. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
Cumming P; Wong DF; Gillings N; Hilton J; Scheffel U; Gjedde A
J Cereb Blood Flow Metab; 2002 May; 22(5):596-604. PubMed ID: 11973432
[TBL] [Abstract][Full Text] [Related]
9. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
Seeman P; Tallerico T; Ko F
Synapse; 2003 Sep; 49(4):209-15. PubMed ID: 12827639
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
Ginovart N; Wilson AA; Houle S; Kapur S
Biol Psychiatry; 2004 Jun; 55(12):1188-94. PubMed ID: 15184038
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.
McCormick PN; Kapur S; Reckless G; Wilson AA
Synapse; 2009 Nov; 63(11):998-1009. PubMed ID: 19598174
[TBL] [Abstract][Full Text] [Related]
12. Hypothermia reduces the rate of dissociation of specific ligands from dopamine-D2 and 5-hydroxytryptamine1A receptors in the mouse brain in vivo.
Stenfors C; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):479-86. PubMed ID: 11692232
[TBL] [Abstract][Full Text] [Related]
13. Link between dopamine D1 and D2 receptors in rat and human striatal tissues.
Seeman P; Tallerico T
Synapse; 2003 Mar; 47(4):250-4. PubMed ID: 12539197
[TBL] [Abstract][Full Text] [Related]
14. SIC, an intracerebral beta(+)-range-sensitive probe for radiopharmacology investigations in small laboratory animals: binding studies with (11)C-raclopride.
Zimmer L; Hassoun W; Pain F; Bonnefoi F; Lanièce P; Mastrippolito R; Pinot L; Pujol JF; Leviel V
J Nucl Med; 2002 Feb; 43(2):227-33. PubMed ID: 11850489
[TBL] [Abstract][Full Text] [Related]
15. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
Shuto T; Seeman P; Kuroiwa M; Nishi A
Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
[TBL] [Abstract][Full Text] [Related]
16. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
[TBL] [Abstract][Full Text] [Related]
17. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
Alttoa A; Eller M; Herm L; Rinken A; Harro J
Brain Res; 2007 Feb; 1131(1):138-48. PubMed ID: 17156751
[TBL] [Abstract][Full Text] [Related]
18. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
[TBL] [Abstract][Full Text] [Related]
19. Increased in vivo [11C]raclopride binding to brain dopamine receptors in amphetamine-treated rats.
Kilbourn MR; Domino EF
Eur J Pharmacol; 2011 Mar; 654(3):254-7. PubMed ID: 21262223
[TBL] [Abstract][Full Text] [Related]
20. D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites.
Severson JA; Randall PK
J Pharmacol Exp Ther; 1985 May; 233(2):361-8. PubMed ID: 3158731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
